SARMs (selective androgen receptor modulators) carry a range of serious side effects, from liver damage and hormonal disruption to cardiovascular harm. Despite being marketed as a safer alternative to anabolic steroids, these compounds are not approved by the FDA for human use, and the agency has specifically warned that they are associated with life-threatening health problems including heart attack, stroke, and acute liver failure.
How SARMs Work (and Why “Selective” Is Misleading)
SARMs were developed in the late 1990s to target androgen receptors in muscle tissue while sparing other organs like the prostate, skin, and liver. The idea was to deliver the muscle-building benefits of testosterone without the unwanted effects of traditional steroids. In theory, when a SARM binds to an androgen receptor, it triggers a slightly different shape change in the receptor compared to testosterone, which recruits a different set of helper proteins and activates a different set of genes. This is how selectivity is supposed to work.
In practice, that selectivity is incomplete. SARMs still activate androgen receptors throughout the body, including in the liver, heart, and reproductive system. Their tissue distribution varies, and each tissue expresses its own mix of helper proteins that interact with the drug. The result is that SARMs produce many of the same systemic effects as steroids, just sometimes to a lesser degree. None of these compounds have completed the kind of rigorous, long-term human safety testing that would reveal their full risk profile.
Liver Damage and Acute Liver Injury
One of the most well-documented side effects of SARMs is drug-induced liver injury. Published case reports describe previously healthy men, typically between the ages of 19 and 40, developing jaundice, dark urine, nausea, fatigue, and intense itching after using SARMs for several weeks. The compounds most frequently linked to liver injury are ligandrol (LGD-4033), ostarine (MK-2866), and testolone (RAD-140).
In one case, a 22-year-old man developed worsening jaundice after taking RAD-140 for 16 weeks. His liver enzymes were elevated well above normal ranges, and a biopsy confirmed drug-induced liver injury with inflammation and bile buildup. A review of the medical literature found at least seven published cases of SARM-related liver injury, all reported since 2020, suggesting the problem is only beginning to be recognized as SARM use grows. Liver enzyme levels in these cases ranged from roughly three to fifteen times the upper limit of normal.
What makes this especially concerning is that many users take SARMs for months at a time, sometimes stacking multiple compounds. Liver damage can develop gradually and may not produce obvious symptoms until it’s advanced. Yellowing of the skin or eyes, unusually dark urine, pale stools, or persistent nausea during or after a SARM cycle are red flags.
Testosterone Suppression and Reproductive Harm
SARMs suppress your body’s natural testosterone production. This happens through the same feedback loop that makes anabolic steroids shut down hormone output: when androgen receptors in the brain detect circulating androgens (including SARMs), they signal the pituitary gland to reduce production of the hormones that drive testosterone synthesis. Clinical studies using LGD-4033, RAD-140, and ostarine have all documented measurable decreases in total testosterone levels in male participants.
The consequences of this suppression include fatigue, low libido, erectile dysfunction, mood changes, and testicular shrinkage. The FDA lists both sexual dysfunction and infertility among the serious risks of SARM use. For younger users, whose hormonal systems are still maturing, the disruption could be more significant and harder to reverse. Recovery of natural testosterone production after stopping SARMs is not guaranteed to happen quickly or completely, which is why many users turn to additional drugs for “post-cycle therapy,” introducing yet another layer of unregulated substances and risks.
Cholesterol and Heart Health
SARMs substantially reduce HDL cholesterol, the type that helps protect against heart disease. In a controlled study, participants taking a moderate dose saw their HDL drop by about 13 mg/dL, while those on a higher dose experienced a drop of roughly 18 mg/dL. The placebo group, by comparison, saw almost no change. SARMs also significantly reduced levels of apolipoprotein A1, the primary protein in HDL particles, with higher doses driving larger reductions.
HDL normally helps remove cholesterol from artery walls and transport it back to the liver for disposal. Lower HDL levels mean less of that protective activity, which over time raises the risk of plaque buildup, atherosclerosis, and cardiovascular events. While the study found that the functional quality of remaining HDL particles didn’t change much, the sheer reduction in quantity is still a meaningful cardiovascular risk, especially for someone using SARMs repeatedly over months or years.
Heart Muscle Damage
Beyond cholesterol, there is growing concern about direct effects on the heart muscle itself. Androgen receptor signaling can promote thickening of the heart’s walls, a condition called myocardial hypertrophy. This thickening is a known risk factor for heart failure and sudden cardiac arrest. Men already have higher rates of cardiac hypertrophy than women, partly because of androgen activity, and flooding the body with additional androgen receptor stimulation through SARMs could amplify that risk.
At least one published case describes a healthy young man diagnosed with acute inflammation of the heart muscle (myocarditis) after self-medicating with RAD-140. He presented with shortness of breath and no prior cardiac history. The biological mechanisms are plausible: excessive androgen receptor activation can increase muscle protein production in cardiac cells, alter calcium handling, and shift the balance toward growth in ways the heart isn’t designed to accommodate. The evidence is still limited, but the FDA lists increased risk of heart attack and stroke among the dangers of SARM use.
Androgenic Side Effects
Despite the promise of tissue selectivity, SARMs can still cause the classic androgen-driven side effects they were designed to avoid. Users report acne, oily skin, and hair thinning or accelerated hair loss. Traditional steroids cause these problems partly because testosterone gets converted into a more potent form (DHT) in the skin and hair follicles. SARMs don’t undergo that same conversion, which should theoretically protect against these effects. But androgen receptors in the skin and scalp still respond to SARMs directly, and for people who are genetically susceptible to androgenic hair loss, that stimulation can be enough to trigger or accelerate it.
Psychiatric and Sleep Effects
The FDA’s safety warning includes psychosis, hallucinations, and sleep disturbances among the reported adverse effects of SARMs. Androgen receptors are expressed throughout the brain, and altering their activation can affect mood, cognition, and sleep architecture. Users commonly report irritability, anxiety, and disrupted sleep, particularly during or immediately after a cycle when hormone levels are fluctuating. The hormonal crash that follows SARM use, when natural testosterone is suppressed but the SARM is clearing the system, can produce a period of low-androgen symptoms that closely resemble depression.
Contamination and Mislabeling
Because SARMs are not approved for human use, they exist in a regulatory gray area. They’re typically sold online as “research chemicals” and are manufactured without the quality controls that apply to pharmaceutical drugs. Independent analyses of SARM products have repeatedly found that labels don’t match contents: some contain different SARMs than advertised, some contain no active compound at all, and some are contaminated with anabolic steroids or other undisclosed substances. This means that even someone who has researched a specific SARM’s risk profile may be unknowingly taking something entirely different, with an unpredictable set of side effects.